April 2024

Week in Review: Cardiologist killed in murder-suicide | TAVR or SAVR? | FTC's ban of noncompete clauses | Much more ()
Cardiologist killed in apparent murder-suicide | Helping patients stay active | Keto diet may be harmful | Bayer's good news ()
Week in Review: Johnson & Johnson's big move | AUC requirement dropped | ACC.24 | TAVR vs. SAVR after 5 years ()
Week in Review: Catheter kits recalled after patient death | FDA approves Abbott’s TriClip | Paclitaxel-coated devices ()
Cardiologists see value in AI-based plaque assessments | Confirmed: Paclitaxel-coated devices are safe ()